DanCann Pharma A/S publishes Q4-2022 report
COPENHAGEN, Denmark, 28 February 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announce that the Company has published its report for the fourth quarter of 2022. The Q4-2022 report is available as an attached document to this press release and at www.dancann.com.SUMMARY: GROUP KEY FIGURES Q4 2022 KDKK 01/01/22 01/01/21 01/10/22 - 31/12/22 01/10/21 - 31/12/21 - 31/12/22 - 31/12/21 Net sales 5.707 874 2.101 874 Operating